| 摘要 |
A pharmaceutical composition for preventing fibrosis, treating fibrosis, and/or preventing the progression of fibrosis contains stanniocalcin 1 (STC1) as an active ingredient; or a pharmaceutical composition for preventing pulmonary fibrosis, treating pulmonary fibrosis, and/or preventing the progression of pulmonary fibrosis contains STC1 as an active ingredient. A method for treating, preventing or suppressing progression of fibrosis using the above pharmaceutical composition. The fibrosis may be pulmonary fibrosis. |
